4th Quarter - Report

MAYO CLINIC for MAYO CLINIC

Firm
Client
Income
—
Expenses
$320,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Railroads RRR

High Speed Rail; Freight Rail Corridor

LobbyistCovered position, as disclosed
JENNIFER MALLARD —

Contacted: Natl Institutes of Health (NIH); Transportation, Dept of (DOT); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Science/Technology SCI

Telemedicine; Medical Device Technologies; New Diagnostic Tests; Precision Medicine

LobbyistCovered position, as disclosed
JENNIFER MALLARD —

Contacted: Transportation, Dept of (DOT); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); SENATE; Food & Drug Administration (FDA)

Medical/Disease Research/Clinical Labs MED

Lab Payments; Lab Oversight; Research Funding; Precision Medicine

LobbyistCovered position, as disclosed
JENNIFER MALLARD Director, Federal Government Relations

Contacted: Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Natl Institutes of Health (NIH); Transportation, Dept of (DOT); Food & Drug Administration (FDA)

Health Issues HCR

Hospital Payments, Physician Payments, Healthcare Grants, Medical Record Privacy, Telemedicine, ICD-10, LDTs

LobbyistCovered position, as disclosed
JENNIFER MALLARD Director, Federal Government Relations

Contacted: Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); SENATE; Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Transportation, Dept of (DOT)

Medicare/Medicaid MMM

Medicare physician payments; Medicare hospital payments; Medicare clinical lab payments; Teaching hospital payments; ACOs; CMMI; Quality Issues; Telemedicine; 340B Program; Generic Drug Pricing.

LobbyistCovered position, as disclosed
JENNIFER MALLARD Director, Federal Government Relations

Contacted: HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); SENATE; Transportation, Dept of (DOT); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.